Invesco Ltd. - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 108 filers reported holding INTERSECT ENT INC in Q2 2021. The put-call ratio across all filers is 2.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$392,000
-34.4%
13,981
-36.2%
0.00%
Q4 2021$598,000
-3.2%
21,925
-3.5%
0.00%
Q3 2021$618,000
+85.0%
22,720
+16.0%
0.00%
Q2 2021$334,000
-0.6%
19,590
+21.9%
0.00%
Q1 2021$336,000
+15.5%
16,068
+26.7%
0.00%
Q4 2020$291,000
-95.9%
12,684
-97.1%
0.00%
-100.0%
Q3 2020$7,151,000
+31.3%
438,451
+9.0%
0.00%0.0%
Q2 2020$5,446,000
+18.1%
402,175
+3.3%
0.00%0.0%
Q1 2020$4,612,000
-53.4%
389,226
-2.0%
0.00%
-33.3%
Q4 2019$9,894,000
+27.8%
397,362
-12.7%
0.00%
+50.0%
Q3 2019$7,742,000
-84.5%
455,170
-79.2%
0.00%
-84.6%
Q2 2019$49,789,000
-11.9%
2,187,559
+24.5%
0.01%
-31.6%
Q1 2019$56,496,000
+14.3%
1,757,280
+0.2%
0.02%0.0%
Q4 2018$49,423,000
-3.0%
1,753,846
-1.0%
0.02%
+18.8%
Q3 2018$50,928,000
-17.8%
1,771,406
+7.1%
0.02%
-20.0%
Q2 2018$61,925,000
+8.5%
1,653,527
+13.9%
0.02%
-4.8%
Q1 2018$57,052,000
+891.2%
1,451,704
+717.1%
0.02%
+950.0%
Q4 2017$5,756,000
+37.9%
177,662
+32.6%
0.00%0.0%
Q3 2017$4,173,000
+190.8%
133,954
+110.1%
0.00%
+100.0%
Q4 2015$1,435,000
-4.5%
63,766
-0.8%
0.00%0.0%
Q3 2015$1,503,000
+29960.0%
64,250
+33538.7%
0.00%
Q2 2015$5,0001910.00%
Other shareholders
INTERSECT ENT INC shareholders Q2 2021
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders